Stay updated on ctDNA-Guided Optimization Clinical Trial
Sign up to get notified when there's something new on the ctDNA-Guided Optimization Clinical Trial page.

Latest updates to the ctDNA-Guided Optimization Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1. The study record content remains unchanged.SummaryDifference0.1%

- Check7 days agoChange DetectedThe record presents details for a Phase II trial comparing ctDNA-guided and scan-guided treatment for metastatic colorectal cancer. It reports that the study was terminated due to slow accrual, with six participants enrolled, and includes the study design, eligibility criteria, outcome measures, and study documents.SummaryDifference47%

- Check14 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2, while the study record remains unavailable behind a 403 error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2. The study page continues to display a 403 error.SummaryDifference1%

- Check42 days agoChange DetectedThe page continues to display a 403 Forbidden error. The footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, resulting in an inaccessible view of the study details. The error page replaces the previous study content and navigation.SummaryDifference18%

Stay in the know with updates to ctDNA-Guided Optimization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ctDNA-Guided Optimization Clinical Trial page.